| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Spironolactone for heart failure with preserved ejection fraction.
|
N Engl J Med
|
2014
|
7.48
|
|
2
|
Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.
|
N Engl J Med
|
2015
|
4.39
|
|
3
|
Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis.
|
Lancet
|
2013
|
4.08
|
|
4
|
From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene.
|
Proc Natl Acad Sci U S A
|
2008
|
3.39
|
|
5
|
Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction.
|
Circ Heart Fail
|
2011
|
2.92
|
|
6
|
Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
|
Lancet
|
2011
|
2.59
|
|
7
|
Clinical problem-solving. Anchors away.
|
N Engl J Med
|
2007
|
2.02
|
|
8
|
Cardiovascular risk assessment of the liver transplant candidate.
|
J Am Coll Cardiol
|
2011
|
1.89
|
|
9
|
Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension.
|
Am J Cardiol
|
2009
|
1.80
|
|
10
|
Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.
|
Circ Heart Fail
|
2013
|
1.40
|
|
11
|
Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction.
|
Am J Cardiol
|
2012
|
1.28
|
|
12
|
Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction.
|
Circ Heart Fail
|
2013
|
1.22
|
|
13
|
Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis.
|
J Invest Dermatol
|
2013
|
1.19
|
|
14
|
Prognostic value of left ventricular end-systolic volume index as a predictor of heart failure hospitalization in stable coronary artery disease: data from the Heart and Soul Study.
|
J Am Soc Echocardiogr
|
2008
|
1.13
|
|
15
|
The emerging epidemic of heart failure with preserved ejection fraction.
|
Curr Heart Fail Rep
|
2013
|
1.11
|
|
16
|
Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α.
|
Am J Respir Crit Care Med
|
2014
|
1.11
|
|
17
|
C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study.
|
Eur J Heart Fail
|
2007
|
1.10
|
|
18
|
Association of low-grade albuminuria with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network (HyperGEN) study.
|
Circulation
|
2013
|
1.07
|
|
19
|
Usefulness of electrocardiographic QT interval to predict left ventricular diastolic dysfunction.
|
Am J Cardiol
|
2011
|
1.02
|
|
20
|
Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction.
|
Am J Cardiol
|
2013
|
1.00
|
|
21
|
Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis.
|
Clin Exp Rheumatol
|
2012
|
0.99
|
|
22
|
Relation of short-term heart rate variability to incident heart failure (from the Multi-Ethnic Study of Atherosclerosis).
|
Am J Cardiol
|
2013
|
0.98
|
|
23
|
Four-dimensional flow assessment of pulmonary artery flow and wall shear stress in adult pulmonary arterial hypertension: results from two institutions.
|
Magn Reson Med
|
2014
|
0.96
|
|
24
|
Right heart structural changes are independently associated with exercise capacity in non-severe COPD.
|
PLoS One
|
2011
|
0.95
|
|
25
|
Increased arterial wave reflection magnitude: a novel form of stage B heart failure?
|
J Am Coll Cardiol
|
2012
|
0.93
|
|
26
|
Systemic sclerosis and the heart: current diagnosis and management.
|
Curr Opin Rheumatol
|
2011
|
0.93
|
|
27
|
Diastolic electromechanical coupling: association of the ECG T-peak to T-end interval with echocardiographic markers of diastolic dysfunction.
|
Circ Arrhythm Electrophysiol
|
2012
|
0.91
|
|
28
|
Rationale and Design of the Echocardiographic Study of Hispanics/Latinos (ECHO-SOL).
|
Ethn Dis
|
2015
|
0.89
|
|
29
|
Time-resolved magnetic resonance angiography: evaluation of intrapulmonary circulation parameters in pulmonary arterial hypertension.
|
J Magn Reson Imaging
|
2011
|
0.89
|
|
30
|
Statins in the prevention of venous thromboembolism: a meta-analysis of observational studies.
|
Thromb Res
|
2011
|
0.88
|
|
31
|
Heart failure in North America.
|
Curr Cardiol Rev
|
2013
|
0.87
|
|
32
|
Risk assessment in pulmonary hypertension associated with heart failure and preserved ejection fraction.
|
J Heart Lung Transplant
|
2012
|
0.85
|
|
33
|
Inhibition of the late sodium current slows t-tubule disruption during the progression of hypertensive heart disease in the rat.
|
Am J Physiol Heart Circ Physiol
|
2013
|
0.85
|
|
34
|
Carbon monoxide diffusing capacity and mortality in pulmonary arterial hypertension.
|
J Heart Lung Transplant
|
2009
|
0.83
|
|
35
|
Noninvasive estimation of left ventricular compliance using three-dimensional echocardiography.
|
J Am Soc Echocardiogr
|
2012
|
0.82
|
|
36
|
Current perspectives on systemic hypertension in heart failure with preserved ejection fraction.
|
Curr Cardiol Rep
|
2014
|
0.82
|
|
37
|
Association of serum triiodothyronine with B-type natriuretic peptide and severe left ventricular diastolic dysfunction in heart failure with preserved ejection fraction.
|
Am J Cardiol
|
2012
|
0.80
|
|
38
|
Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients.
|
Am J Ther
|
2008
|
0.80
|
|
39
|
Treatment of acute heart failure in the emergency department.
|
Expert Rev Cardiovasc Ther
|
2013
|
0.79
|
|
40
|
Hematopoietic stem cell transplantation for systemic sclerosis: if you are confused, remember: "it is a matter of the heart".
|
J Rheumatol
|
2012
|
0.79
|
|
41
|
MDCT bolus tracking data as an adjunct for predicting the diagnosis of pulmonary hypertension and concomitant right-heart failure.
|
AJR Am J Roentgenol
|
2011
|
0.78
|
|
42
|
Letter by Psaty et al regarding article, "Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes".
|
Circulation
|
2015
|
0.78
|
|
43
|
Association of African American race with elevated pulmonary artery diastolic pressure: data from the Heart and Soul Study.
|
J Am Soc Echocardiogr
|
2007
|
0.77
|
|
44
|
SERCA2a gene therapy for the prevention of sudden cardiac death: a future theranostic for heart failure?
|
Circulation
|
2012
|
0.77
|
|
45
|
Association of comorbidity burden with abnormal cardiac mechanics: findings from the HyperGEN study.
|
J Am Heart Assoc
|
2014
|
0.77
|
|
46
|
Polycystic ovary syndrome is associated with higher left ventricular mass index: the CARDIA women's study.
|
J Clin Endocrinol Metab
|
2012
|
0.76
|
|
47
|
Classification of patients with acute heart failure syndromes in the emergency department.
|
Circ Heart Fail
|
2012
|
0.76
|
|
48
|
Autologous HSCT for systemic sclerosis - Authors' reply.
|
Lancet
|
2013
|
0.75
|
|
49
|
Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function.
|
J Clin Invest
|
2017
|
0.75
|
|
50
|
Reply: Is Pump the Answer to Heart Failure With Preserved Ejection Fraction?
|
JACC Heart Fail
|
2016
|
0.75
|
|
51
|
HIV-Related Myocardial Vulnerability to Infarction and Coronary Artery Disease.
|
J Am Coll Cardiol
|
2016
|
0.75
|